Tomorrow’s Analytical Cannabis Track Keynote Talk—Day 2
September 14—Baltimore, Maryland—Lori Dodson, Deputy Director of the Maryland Medical Cannabis Commission, will give a special welcome talk tomorrow in the analytical meeting room at 9:00 a.m. The talk is titled “Special Welcome from the Maryland Medical Cannabis Commission.”
Lori Dodson, Deputy Director of the Maryland Medical Cannabis Commission, will give a special welcome talk tomorrow in the analytical meeting room at 9:00 a.m. The talk is titled “Special Welcome from the Maryland Medical Cannabis Commission.”
Join Lori Dodson from the Maryland Medical Cannabis Commission for a special welcome to Maryland to our 2021 Cannabis Science Conference East attendees. Over her career at the Commission, Lori oversaw laboratory compliance and worked to advance cannabis science and education.
Lori Dodson currently serves as the Deputy Director for the Maryland Medical Cannabis Commission. During her time with the Commission, Lori has been actively involved in developing policies and regulations for the medical cannabis industry in Maryland, as well as developing criteria and tolerances for the laboratories registered to certify medical cannabis. Prior to coming on board at the commission, Lori was a Program Coordinator for the Maryland Department of Health and Mental Hygiene-Office of Health Care Quality.
For more information on the analytical track, please visit the 2021 Cannabis Science Conference East Final Program & Exhibitor Guide.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
